Aytu Net Debt To E B I T D A from 2010 to 2024
| AYTU Stock | USD 1.38 0.04 2.99% |
Net Debt To EBITDA | First Reported 2010-12-31 | Previous Quarter 4.81916996 | Current Value (37.19) | Quarterly Volatility 10.01958702 |
Check Aytu BioScience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aytu BioScience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.7 M, Interest Expense of 4.6 M or Selling General Administrative of 12.1 M, as well as many indicators such as Price To Sales Ratio of 304, Dividend Yield of 0.0 or PTB Ratio of 3.34. Aytu financial statements analysis is a perfect complement when working with Aytu BioScience Valuation or Volatility modules.
Aytu | Net Debt To E B I T D A |
Latest Aytu BioScience's Net Debt To E B I T D A Growth Pattern
Below is the plot of the Net Debt To E B I T D A of Aytu BioScience over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). Aytu BioScience's Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aytu BioScience's overall financial position and show how it may be relating to other accounts over time.
| Net Debt To E B I T D A | 10 Years Trend |
|
Net Debt To E B I T D A |
| Timeline |
Aytu Net Debt To E B I T D A Regression Statistics
| Arithmetic Mean | (1.29) | |
| Coefficient Of Variation | (775.13) | |
| Mean Deviation | 4.79 | |
| Median | 0.98 | |
| Standard Deviation | 10.02 | |
| Sample Variance | 100.39 | |
| Range | 42.0111 | |
| R-Value | (0.38) | |
| Mean Square Error | 92.74 | |
| R-Squared | 0.14 | |
| Significance | 0.17 | |
| Slope | (0.84) | |
| Total Sum of Squares | 1,405 |
Aytu Net Debt To E B I T D A History
About Aytu BioScience Financial Statements
Aytu BioScience shareholders use historical fundamental indicators, such as Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Although Aytu BioScience investors may analyze each financial statement separately, they are all interrelated. The changes in Aytu BioScience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aytu BioScience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Debt To EBITDA | 4.82 | (37.19) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.